RCEL

AVITA Medical, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$16.2

Price (1 Year)

$16.59 $3.4

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %20.2 / %30
Non-compliant assets / Total market cap %2.6 / %30
Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.

Website

Analysis (Turkish): RCEL Hissesi Caiz mi, Helal mi? AVITA Medical, Inc. Katılım Analizi